371975-46-1 Usage
General Description
Tert-butyl 4-hydroxy-4-vinylpiperidine-1-carboxylate is a chemical compound with the molecular formula C13H23NO3. It is a derivative of piperidine, a heterocyclic amine, and contains both a tert-butyl group and a vinyl group. This chemical is commonly used as a reactant in organic synthesis, where it can undergo various reactions to produce different compounds. It is also known for its use as a protective group in peptide synthesis, where it can be used to protect the amine group of an amino acid to prevent undesired reactions during peptide bond formation. Tert-butyl 4-hydroxy-4-vinylpiperidine-1-carboxylate is a versatile and valuable compound in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 371975-46-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,1,9,7 and 5 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 371975-46:
(8*3)+(7*7)+(6*1)+(5*9)+(4*7)+(3*5)+(2*4)+(1*6)=181
181 % 10 = 1
So 371975-46-1 is a valid CAS Registry Number.
371975-46-1Relevant articles and documents
Catalytic Radical-Polar Crossover Reactions of Allylic Alcohols
Touney, Eric E.,Foy, Nicholas J.,Pronin, Sergey V.
supporting information, p. 16982 - 16987 (2018/12/14)
Radical-polar crossover hydrofunctionalizations of tertiary allylic alcohols are described. Depending on the structure of the catalyst, corresponding epoxides or semipinacol rearrangement products are selectively obtained in good yields. Experimental evidence points to the participation of alkylcobalt complexes as electrophilic intermediates.
PYRAZOLO PYRIMIDINE DERIVATIVES
-
Paragraph 0332-0333, (2013/03/26)
The present invention relates to pyrazolo pyrimidine derivatives, to methods of preparing these, to combinations and pharmaceutical composition comprising these, and to their use in the treatment of diseases and disorders which may for example involve autoimmune diseases, angiogenesis, pain, and/or inflammatory diseases.
